bumetanide 0.5 mg
INDICATIONS AND USAGE Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.
upsher-smith laboratories, llc
ROUND YELLOW US 40 0 5
US 40 0 5 ROUND YELLOW
Related Pills
bumetanide 0.5 mg
upsher-smith laboratories, llc
bumetanide 1 mg
upsher-smith laboratories, llc
bumetanide 2 mg
upsher-smith laboratories, llc
bumetanide 2 mg
upsher-smith laboratories, llc
bumetanide 2 mg
upsher-smith laboratories, llc
bumetanide 2 mg
upsher-smith laboratories, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
BUMEtanIDE Tablets, USP, for oral administration, are available as:
BUMEtanIDE Tablets, USP, 0.5 mg are available as light green, round tablets with functional scoring; one side scored and debossed "U-S" above the score and "40" below the score, and the other side unscored and debossed "0.5". Tablets are supplied as: NDC 0832-0540-11 bottles of 100
BUMEtanIDE Tablets, USP, 1 mg are available as yellow, round tablets with functional scoring; one side scored and debossed "U-S" above the score and "41" below the score, and the other side unscored and debossed "1". Tablets are supplied as: NDC 0832-0541-11 bottles of 100 NDC 0832-0541-10 bottles of 1000
BUMEtanIDE Tablets, USP , 2 mg are available as light red, round tablets with functional scoring; one side scored and debossed "U-S" above the score and "42" below the score, and the other side unscored and debossed "2". Tablets are supplied as: NDC 0832-0542-11 bottles of 100 NDC 0832-0542-10 bottles of 1000 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required.
More pills like ROUND US 40 0 5